BV

Beena Verma

Active Director Director DIN 08893770
DIN 08893770 First appointment Sep 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Beena Verma

Data last updated:

Beena Verma is a Director at Kemiras Drugs Private Limited (since 2020). The company operates in Chemicals. Kemiras Drugs Private Limited reported revenue of ₹24.7 Lakh (FY 2025).

DIN 08893770
Primary Designation Director
Industry Chemicals
First Appointment 25 Sep 2020
Oldest Company Age 6 yrs
Largest company Kemiras Drugs Private Limited · ₹24.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kemiras Drugs Private Limited U24290UP2020PTC135201
Director25 Sep 20202020₹24.7 Lakh (FY 2025)Active

Board colleagues of Beena Verma

Directorship timeline

Open interactive timeline →
Kemiras Drugs Private Limited
Premium access

Shareholding and investment profile for Beena Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Beena Verma

Beena Verma currently holds 1 directorship: Kemiras Drugs Private Limited (Director, since 25 Sep 2020, revenue ₹24.7 Lakh (FY 2025)).

Beena Verma was first appointed on 25 Sep 2020 as Director at Kemiras Drugs Private Limited.

The current boards of Beena Verma's companies include Dadhich Kumar Verma (Kemiras Drugs Private Limited), Devang Verma (Kemiras Drugs Private Limited), Rama Shankar Verma (Kemiras Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available